China SXT Pharmaceuticals (SXTC) executes a 1-for-100 reverse stock split
China SXT Pharmaceuticals will carry out a 1-for-100 consolidation of its Class A ordinary shares, effective October 26, 2026, with trading on a post-consolidation basis beginning that same day. According to the analysis cited in the report, this is a measure microcaps often use to maintain compliance with listing requirements and restore trading dynamics. The information comes from the company's original press release, distributed by PR Newswire.
In 35 seconds
- The 1-for-100 reverse split applies to China SXT Pharmaceuticals' Class A ordinary shares.
- The consolidation takes effect on October 26, 2026, and post-consolidation trading begins that day.
- The cited analysis notes such measures are used by microcaps to maintain compliance with listing requirements.
IASummary generated by artificial intelligence from a story by TradingView. It may contain errors: the original source prevails.




Comments
Be respectful. Comments reported by several people are hidden until a moderator reviews them.
You do not need an account to read, only to comment. Sign in with a code sent to your email or with your Google account. We only show the name you choose, never your email.